Carregant...
Intravenous Immunoglobulin Reduces Tau Pathology and Preserves Neuroplastic Gene Expression in the 3xTg Mouse Model of Alzheimer’s Disease
Despite recent negative results of the Gammaglobulin Alzheimer’s Partnership (GAP) trial, the good tolerability to intravenous immunoglobulin (IVIG) and its potential benefit for patient subpopulations have highlighted the importance of understanding IVIG’s mechanism of action. IVIG contains antibod...
Guardat en:
Publicat a: | Curr Alzheimer Res |
---|---|
Autors principals: | , , , |
Format: | Artigo |
Idioma: | Inglês |
Publicat: |
2014
|
Matèries: | |
Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6364843/ https://ncbi.nlm.nih.gov/pubmed/25156574 |
Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|